Table 1.
Clinical and demographic data of participants according to the MetSyn status
| Variable | Without MetSyn (n = 92) Mean ± SD | With MetSyn (n = 41) Mean ± SD | p value |
|---|---|---|---|
| Age (year) | 65 ± 8 | 66 ± 9 | 0.27 |
| Creatinine (mg/dL) | 1.0 ± 0.2 | 1.0 ± 0.3 | 0.15 |
| Gender (Female, %) | 63% | 63% | 0.97 |
| Ethnicity (Caucasian, %) | 60% | 44% | 0.09 |
| Smoking (current, %) | 8% | 10% | 0.69 |
| Weight (Kg) | 77 ± 17 | 91 ± 18 | < 0.01 |
| BMI (Kg/m2) | 28 ± 5 | 32 ± 4 | < 0.01 |
| Total cholesterol (mg/dL) | 197 ± 44 | 177 ± 39 | 0.01 |
| LDL-cholesterol (mg/dL) | 116 ± 39 | 101 ± 36 | < 0.05 |
| Any lipid-lowering medication (Yes, %) | 28% | 47% | < 0.05 |
| Waist circumference (cm)* | 93 ± 13 | 107 ± 14 | < 0.01 |
| Glucose (mg/dL)* | 93 ± 16 | 107 ± 24 | < 0.01 |
| Triglycerides (mg/dL)* | 94 ± 46 | 151 ± 71 | < 0.01 |
| HDL-cholesterol (mg/dL)* | 62 ± 20 | 46 ± 11 | < 0.01 |
| Hypertension (Yes, %)* | 42% | 80% | < 0.01 |
MetSyn: Metabolic Syndrome; SD: standard deviation; BMI: body mass index; HDL: high-density lipoprotein; LDL: low-density lipoprotein
*
Metabolic Syndrome component.